Back
Novo Nordisk A/S Quote, Financials, Valuation and Earnings
Sponsored
NONOF
Sponsored
DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon
Discover our top DeFi pick for potentially massive gains now (before it's too late).
Buy
78
NONOF
Novo Nordisk A/S
Last Price:
130.70
Seasonality Move:
4.69%
7 Day Trial
ALL ACCESS PASS
$
7
BREAKING: Elon Musk's Secret A.I. Project Set to Plunge Millions of Americans Into Poverty
Click here now to prepare yourself for what's around the cornerNovo Nordisk A/S Price Quote
$130.70
+1.95 (+1.51%)
(Updated: May 13, 2024 at 6:55 PM ET)
Novo Nordisk A/S Key Stats
Buy
78
Novo Nordisk A/S (NONOF)
is a Buy
Day range:
$127.00 - $130.96
52-week range:
$74.70 - $140.32
Dividend yield:
1.06%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
2.5K
Avg. volume:
23.4K
1-year change:
51.56%
Market cap:
$576B
Revenue:
$25.1B
EPS:
$3.8
How Much Does Novo Nordisk A/S Make?
-
How Much Are Novo Nordisk A/S's Sales Annually?
NONOF Revenues are $25.1B -
How Much Profit Does Novo Nordisk A/S's Make A Year?
NONOF net income is $7.9B
Is Novo Nordisk A/S Growing As A Company?
-
What Is Novo Nordisk A/S's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.34% -
What Is Novo Nordisk A/S's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0.5%
Novo Nordisk A/S Stock Price Performance
-
Did Novo Nordisk A/S Stock Go Up Last Month?
Novo Nordisk A/S share price went up by 2.98% last month -
Did NONOF's Share Price Rise Over The Last Year?
NONOF share price rose by 51.56% over the past 1 year
What Is Novo Nordisk A/S 52-Week High & Low?
-
What Is Novo Nordisk A/S’s 52-Week High Share Price?
Novo Nordisk A/S has traded as high as $140.32 over the past 52 weeks -
What Is Novo Nordisk A/S’s 52-Week Low Share Price?
Novo Nordisk A/S has traded as low as $74.70 over the past 52 weeks
Novo Nordisk A/S Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Novo Nordisk A/S?
-
How Much Debt Does Novo Nordisk A/S Have?
Total long term debt quarterly is $3.8B -
How Much Cash Does Novo Nordisk A/S Have?
Cash and short term investments quarterly total is $5.3B -
What Is Novo Nordisk A/S’s Book Value Per Share?
Book value per share is 2.95
Is Novo Nordisk A/S Cash Flow Positive?
-
What Is NONOF Cash Flow From Operations?
Cash flow from operations (TTM) is $12.9B -
What Is Novo Nordisk A/S’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$8B -
What Is Novo Nordisk A/S’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$5B
Novo Nordisk A/S Return On Invested Capital
-
Is Management Doing A Good Job?
NONOF return on invested capital is 63.4% -
What Is Novo Nordisk A/S Return On Assets?
ROA measures how assets are converting to revenues and is 27.17% -
What Is NONOF Return On Equity?
ROE is a measure of profitability and is 82.75%
Novo Nordisk A/S Earnings Date & Stock Price
-
What Is Novo Nordisk A/S's Stock Price Today?
A single share of NONOF can be purchased today for 128.75 -
What Is Novo Nordisk A/S’s Stock Symbol?
Novo Nordisk A/S trades on the otcm under the ticker symbol: NONOF -
When Is Novo Nordisk A/S’s Next Earnings Date?
The next quarterly earnings date for Novo Nordisk A/S is scheduled on August 7, 2024 -
When Is NONOF's next ex-dividend date?
Novo Nordisk A/S's next ex-dividend date is March 22, 2024 -
How To Buy Novo Nordisk A/S Stock?
You can buy Novo Nordisk A/S shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Novo Nordisk A/S Competitors
-
Who Are Novo Nordisk A/S's Competitors?
Below is a list of companies who compete with Novo Nordisk A/S or are related in some way:
Novo Nordisk A/S Dividend Yield
-
What Is NONOF Dividend Yield?
Novo Nordisk A/S’s dividend yield currently is 1.06% -
What Is Novo Nordisk A/S’s Payout Ratio?
Novo Nordisk A/S’s payout ratio is 42.26% -
When Did Novo Nordisk A/S Last Pay A Dividend?
The latest dividend pay date is May 14, 2024 -
What Is Novo Nordisk A/S’s Dividend Per Share?
Novo Nordisk A/S pays a dividend of $0.00 per share
Novo Nordisk A/S Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 50.35% | 0% |
Revenue: | 34.34% | 2.97% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 1 |
Sell Recommendations: | 0 |
Price Target: | 95.19 |
Downside from Last Price: | -26.06% |